AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme.


3. Change history

Version number: V01.00

Change details: New protocol for AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) vaccine.

Date: 21 January 2021

Version number: V02.00

Change details: Updated protocol to reflect Armed Services staff roles

Date: 02 February 2021

Version number: V02.1

Change details: Clinical annex updated

Date: 22 February 2021

Contact

Email: Covid19VaccinePolicyMailbox@gov.scot

Back to top